These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 28640996)
1. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response. Yong Y; Zhang C; Gu Z; Du J; Guo Z; Dong X; Xie J; Zhang G; Liu X; Zhao Y ACS Nano; 2017 Jul; 11(7):7164-7176. PubMed ID: 28640996 [TBL] [Abstract][Full Text] [Related]
2. A GdW Chen L; Zhang Y; Zhang X; Lv R; Sheng R; Sun R; Du T; Li Y; Qi Y Molecules; 2021 Dec; 27(1):. PubMed ID: 35011360 [TBL] [Abstract][Full Text] [Related]
3. Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor. Zhou X; Liu H; Zheng Y; Han Y; Wang T; Zhang H; Sun Q; Li Z ACS Appl Mater Interfaces; 2020 Jan; 12(4):4231-4240. PubMed ID: 31912727 [TBL] [Abstract][Full Text] [Related]
4. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia. Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400 [TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-manipulated radiocatalytic sensitizer based on bismuth heteropolytungstate for radiotherapy enhancement. Zhou R; Wang H; Yang Y; Zhang C; Dong X; Du J; Yan L; Zhang G; Gu Z; Zhao Y Biomaterials; 2019 Jan; 189():11-22. PubMed ID: 30384125 [TBL] [Abstract][Full Text] [Related]
6. Bi Zang Y; Gong L; Mei L; Gu Z; Wang Q ACS Appl Mater Interfaces; 2019 May; 11(21):18942-18952. PubMed ID: 31058495 [TBL] [Abstract][Full Text] [Related]
7. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. De Ridder M; Van Esch G; Engels B; Verovski V; Storme G Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408 [TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression. Qi R; Jin W; Wang J; Yi Q; Yu M; Xu S; Jin W Oncol Rep; 2014 May; 31(5):2399-406. PubMed ID: 24604140 [TBL] [Abstract][Full Text] [Related]
9. KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways. Oommen D; Prise KM Biochem Biophys Res Commun; 2012 May; 421(3):538-43. PubMed ID: 22521642 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT. Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α. Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458 [TBL] [Abstract][Full Text] [Related]
13. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors. Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro. Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H Tumori; 2015; 101(5):578-84. PubMed ID: 26350185 [TBL] [Abstract][Full Text] [Related]
15. Using YC-1 to overcome the radioresistance of hypoxic cancer cells. Moon SY; Chang HW; Roh JL; Kim GC; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY Oral Oncol; 2009 Oct; 45(10):915-9. PubMed ID: 19457706 [TBL] [Abstract][Full Text] [Related]
16. Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization. Yang C; Mu G; Zhang Y; Gao Y; Zhang W; Liu J; Zhang W; Li P; Yang L; Yang Z; Gao J; Liu J Adv Mater; 2022 Sep; 34(37):e2202625. PubMed ID: 35906003 [TBL] [Abstract][Full Text] [Related]
17. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species. Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression. Li N; Meng DD; Gao L; Xu Y; Liu PJ; Tian YW; Yi ZY; Zhang Y; Tie XJ; Xu ZQ Radiat Oncol; 2018 Oct; 13(1):210. PubMed ID: 30355300 [TBL] [Abstract][Full Text] [Related]
19. Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy. Wang H; Jia D; Yuan D; Yin X; Yuan F; Wang F; Shi W; Li H; Zhu LM; Fan Q J Nanobiotechnology; 2021 May; 19(1):138. PubMed ID: 33985511 [TBL] [Abstract][Full Text] [Related]
20. Breakthrough of Hypoxia Limitation by Tumor-Targeting Photothermal Therapy-Enhanced Radiation Therapy. Zhang Y; Liu D; Qiao B; Luo Y; Zhang L; Cao Y; Ran H; Yang C Int J Nanomedicine; 2024; 19():6499-6513. PubMed ID: 38946887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]